Insider trading · Q3 2026 · CIK 1549084

ChronoScale Holdings Corp (CHRN) insider trading.

Name: ChronoScale Holdings Corp insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at ChronoScale Holdings Corp reported 3 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions: 3
Purchases (P): 0
Sales (S): 0
Net shares, P minus S: 0
Insiders: 3
Last filed: 2026-08-18

Insiders

Insider	Relationship	Transactions
Wong Jerome	Officer · Chief Financial Officer	1
Jegannathan Rajasekar	Officer · Chief Technology Officer	1
Chen Ying Cenly	Director, Officer · Chief Executive Officer	1

Transactions

3 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-08-16	Wong Jerome	A (A)	300,000	$0	364,771	Form 4
2026-07-22	Jegannathan Rajasekar	A (A)	1,400,000	$0	1,402,587	Form 4
2026-07-13	Chen Ying Cenly	A (A)	2,800,000	$0	2,800,000	Form 4

Transaction codes in this quarter

A: 3

Get CHRN insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1549084&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · CHRN company page · ChronoScale Holdings Corp on SEC.gov

Questions

Are insiders buying or selling ChronoScale Holdings Corp (CHRN)?

In Q3 2026, insiders at ChronoScale Holdings Corp reported 3 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these ChronoScale Holdings Corp insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/chrn.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.